Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

Query: search in
search in
search in
search in

Options:
  Reset


Query: "author" (Brigita %C5%BDajdela) .

1 - 10 / 73
First pagePrevious page12345678Next pageLast page
1.
Prognostic factors of choroidal melanoma in Slovenia, 1986-2008
Boris Jančar, Marjan Budihna, Brigita Drnovšek-Olup, Katrina Novak-Andrejčič, Irena-Hedvika Brovet-Zupančič, Dušica Pahor, 2016, original scientific article

Abstract: Introduction. Choroidal melanoma is the most common primary malignancy of the eye, which frequently metastasizes. The Cancer Registry of Slovenia reported the incidence of choroid melanoma from 1983 to 2009 as stable, at 7.8 cases/million for men and 7.4/million for women. The aim of the retrospective study was to determinate the prognostic factors of survival for choroidal melanoma patients in Slovenia. Patients and methods. From January 1986 to December 2008 we treated 288 patients with malignant choroidal melanoma; 127 patients were treated by brachytherapy with beta rays emitting ruthenium-106 applicators; 161 patients were treated by enucleation. Results. Patients with tumours thickness < 7.2 mm and base diameter < 16 mm were treated by brachytherapy and had 5- and 10-year overall mortality 13% and 32%, respectively. In enucleated patients, 5- and 10-year mortality was higher, 46% and 69%, respectively, because their tumours were larger. Thirty patients treated by brachytherapy developed local recurrence. Twenty five of 127 patients treated by brachytherapy and 86 of 161 enucleated patients developed distant metastases. Patients of age >/= 60 years had significantly lower survival in both treatment modalities. For patients treated by brachytherapy the diameter of the tumour base and treatment time were independent prognostic factors for overall survival, for patients treated by enucleation age and histological type of tumour were independent prognosticators. In first few years after either of treatments, the melanoma specific annual mortality rate increased, especially in older patients, and then slowly decreased. Conclusions. It seems that particularly younger patients with early tumours can be cured, whereby preference should be given to eyesight preserving brachytherapy over enucleation.
Keywords: choroidal melanoma, therapy, brachytherapy, prognostic factors
Published in DiRROS: 09.05.2024; Views: 80; Downloads: 43
.pdf Full text (624,05 KB)
This document has many files! More...

2.
Mirvetuksimab-soravtanzin pri raku jajčnikov, odpornem proti platini in pozitivnem na folatne receptorje [alfa]
Brigita Gregorič, 2024, published professional conference contribution

Keywords: internistična onkologija, rak jajčnikov, kemoterapija
Published in DiRROS: 19.04.2024; Views: 83; Downloads: 21
.pdf Full text (798,97 KB)

3.
Contaminant trends in urban groundwater: case study from Ljubljana (central Slovenia)
Janja Svetina, Joerg Prestor, Brigita Jamnik, Primož Auersperger, Mihael Brenčič, 2024, original scientific article

Abstract: Urban areas can significantly alter the quality status of aquifers if appropriate strategies to prevent and detect groundwater contamination are not implemented in time. The prevention of groundwater contamination should be a priority due to its potential long-term impact on the environment and the high cost of remediation. For effective and sustainable groundwater management, it is crucial to proactively monitor a wide range of compounds to prevent their spread, progression and increasing concentrations. This study is one of the few to analyse the trends of various urban groundwater contaminants (nitrate, sulphate, hexavalent chromium, pesticides, PCE and TCE) from a groundwater management perspective. Characteristic trends are assessed using linear regression and the Mann–Kendall method, while significant changes in trends are determined using the Darken and Pettitt tests. The time span of the analysed trends covers the transition period before and after the implementation of the Water Framework Directive (2000/60/EC) and the Groundwater Directive (2000/60/EC). This study confirms the effectiveness of enforcement measures to protect groundwater quality, as evidenced by several statistically significant decreasing trends. On the other hand, this study emphasises the importance of intervention-targeted sampling campaigns and the reporting of raw analytical values according to the ISO 11843 series of standards. This approach is essential to detect upward trends in emerging contaminants at an early stage and prevent them from reaching levels that could negatively impact the economy or even jeopardise the safety of drinking water supplies.
Keywords: groundwater contamination, contaminant trends, groundwater management, urban aquifer, Ljubljansko polje
Published in DiRROS: 25.03.2024; Views: 141; Downloads: 43
.pdf Full text (7,36 MB)

4.
The diffuse large B-cell lymphoma - where do we stand now in everyday clinical practice
Brigita Gregorič, Vesna Zadnik, Barbara Jezeršek Novaković, 2012, original scientific article

Abstract: Background. Due to superior results observed with the addition of rituximab into treatment of patients with the diffuse large B-cell lymphoma (DLBCL),the R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) regimen and its variants became the standard initial treatment of these patients. However, the treatment recommendations are based on resultsof clinical studies while the conditions of routine treatment are far different from the ones in clinical studies. The aim of this retrospective study was therefore to compare the treatment results of routinelz treated patients with the DLBCL to results reported by some larger studies. Patients and methods. Two hundred and ninety five patients with the DLBCL were treated between 2004 and 2008 according to the then protocol with R-CHOP or R-CHOP-like regimens at the Institute of Oncology Ljubljana. Treatment response was evaluated according to Chesonʼs criteria and the disease-free andoverall survival by means of Kaplan Meier survival curves. Results. Response to treatment in our evaluation diverged from the reported one predominately in the low risk group (international prognostic index [IPI] categorisation) and in the very good prognosis group (revised international prognostic index (R-IPI) categorisation). The determined complete response (CR) rates in other IPI and R-IPI groups were generally within expectations. Also in the disease-free survival the largest discrepancy occurred in the low-risk patient group (3 year disease-free survival rate of 75%) and in the very good prognosis group (4 year disease-free survival rate of 59%). In all other IPI risk groups, the disease-free survival at 3 zears (low intermediate risk 76%, high intermediate risk group 57%, and high risk group 53%) agreed verz well with the quoted ones. Slightly worse was the compliance of the 4 year disease-free survival rates (72% in the good prognosis and 51% in the poor prognosis group) with the results from the literature. The 3 year overall survival rates (low risk patients 87%, high intermediate risk 61% and high risk patients 51%) were somewhat worse than the reported ones in all IPI subgroups except in the low intermediate risk group (82%). On the other hand, the 4 year overall survival rates of the R-IPI categories (94% in the very good prognosis group, 80% in the good prognosis group, 56% in the poor prognosis group) were much better correlated with the data from the literature. Conclusions. In total, the treatment outcomes of routinely treatedpatient with the DLBCL at our institute are quite encouraging when compared to results of some larger studies. There are probably no dilemmas about how to treat young good prognosis patients and patients aged over 60 years at present. However, the 5 year overall survival rate of 76% for the young poor prognosis group is unsatisfying and needs to be improved. At present, quite a few studies are underway to clarify which of the regimens will perform best in this population.
Keywords: diffuse large B-cell lymphoma, R-CHOP, treatment result, routine treatments
Published in DiRROS: 21.03.2024; Views: 113; Downloads: 34
.pdf Full text (621,34 KB)

5.
Qualitative analysis of the minimal Higgins model of glycolysis
Brigita Ferčec, Matej Mencinger, Tatjana Petek, Orhan Ozgur Aybar, Ilknur Kusbeyzi Aybar, 2023, original scientific article

Abstract: Glycolysis, one of the leading metabolic pathways, involves many different periodic oscillations emerging at positive steady states of the biochemical models describing this essential process. One of the models employing the molecular diffusion of intermediates is the Higgins biochemical model to explain sustained oscillations. In this paper, we investigate the center-focus problem for the minimal Higgins model for general values of the model parameters with the help of computational algebra. We demonstrate that the model always has a stable focus point by finding a general form of the first Lyapunov number. Then, varying two of the model parameters, we obtain the first three coefficients of the period function for the stable focus point of the model and prove that the singular point is actually a bi-weak monodromic equilibrium point of type $[1, 2]$. Additionally, we prove that there are two (small) intervals for a chosen parameter $a > 0$ for which one critical period bifurcates from this singular point after small perturbations.
Keywords: biological processes, biochemical models, glycolysis
Published in DiRROS: 18.03.2024; Views: 121; Downloads: 57
.pdf Full text (837,28 KB)
This document has many files! More...

6.
7.
Rak jajčnikov : kaj morate vedeti o bolezni
Brigita Gregorič, Erik Škof, Breda Škrbinc, 2023, not set

Keywords: dejavniki tveganja, simptomi, diagnostika, zdravljenje, neželeni učinki
Published in DiRROS: 06.03.2024; Views: 119; Downloads: 32
.pdf Full text (1,84 MB)

8.
9.
10.
Bolečina pri mamografiji
Zvonko Krajnc, Brigita Hudales, Andreja Kokot, Kristijana Hertl, Maksimiljan Kadivec, Elizabeta Jokan, 2004, published scientific conference contribution

Abstract: Izhodišča. Bolečina pri mamografiji je neprijetrna čutnaa in čustvena izkušnja, povezana z dejansko ali možno okvaro tkiva. Nanjo vplivajo različni dejavniki. Metode. Pri preiskovankah, ki so na Onkološkem inštitutu in po vsejSloveniji opravile mamografijo, smo naredili anketno raziskavo o bolečini pri tej preiskavi. Rezultati. Asimptomatske preiskovanke občutijo manjšo jakost bolečine kot simptomatske. `lečina preiskovank v Sloveniji ne zaužije premedikacije pred mamografijo. Zaključki. Informiranje preiskovank o poteku preiskave in vnaprejšne pričakovanje bolečine je pomembno pri zmanjševanju bolečine. velik vpliv na občutenje bolečine ima tudi radiološki inženir, ki jepo mnenju preiskovank pomembno vplival na zmanjševanje bolečine pri mamografiji.
Published in DiRROS: 01.12.2023; Views: 228; Downloads: 64
.pdf Full text (746,54 KB)

Search done in 0.29 sec.
Back to top